Indonesia Singapore Malaysia Vietnam Thailand Philippines Myanmar

India Greater China Rest of Asia World

E-Commerce & Internet Economy Technology Real Estate and Infrastructure Financial Services Social Infrastructure Deals Barometer

Chinese AI drug discovery startup XtaIPi secures $400m co-led by OrbiMed, HOPU

Chinese AI drug discovery startup XtaIPi secures $400m co-led by OrbiMed, HOPU

12 August, 2021

Shenzhen-based Chinese AI drug discovery platform XtalPi has raked in $400 million in a Series D round of financing.

Printed by Unregistered user on Fri, 22 Sep 2023 00:52:05 GMT

drug discovery SoftBank Vision Fund 2 XtalPi

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

Related Stories

Venture Capital

Chinese pharmaceutical tech firm XtalPi nets $319m in Series C round

By far, the firm has served over 70 drugmakers across markets such as the US, Europe, China and Japan.

Warburg leads $255m Series C in HK-based AI drug discovery firm Insilico Medicine

Min Fang, managing director at Warburg Pincus, will join Insilico's board of directors.